Article Published In Oncotarget Explores Cellular Rejuvenation Diets

Oncotarget is a successful online medical journal which was established in 2010. It is a peer-reviewed and open access journal which is published by Impact Journals. The co-founders and editors-in-chief of this journal are Dr. Mikhail Blagosklonny and Andrei V. Gudkov, both researchers and professors at the Roswell Park Cancer Institute in Buffalo, New York.

Initially, Oncotarget was focused on the medical field of Oncology only. Its success in this field has led to Oncotarget also publishing articles from a large number of other medical fields such as Neurology, Metabolism, Cell Biology, Endocrinology, and many others as well. The articles that are published in Oncotarget are often cited in other research papers. The journal is peer reviewed and is published by Impact Journals.

Starting to publish research articles from fields other than Oncology helped to fulfill one of the primary missions of Oncotarget which is to break down the walls between different medical specialties. The end result that Oncotarget wants to contribute towards is the ultimate end of life with diseases. They support both basic and clinical science in support of this goal.

One research paper that was recently published in Oncotarget was about how nutrition plays a role in cellular rejuvenation. Research has shown that restricting the amount of dietary energy a person eats leads to them having an extended lifespan. It also slows down aging processes. By eating less people can lead a longer and better life. This can be done through periodic fasting as has been shown in research involving mice. The mice that were sedentary and obese were much more likely to experience a premature death in these experiments. Oncotarget is also available on Dove Press.

This new research was conducted by Patricia Huebbe, Gerald Rimbach, and Anke Schloesser who are colleagues at the University of Kiel in Germany. They used nutritional geometry approaches in order to determine that the diets that lead to longevity are not the diets that lead to the best reproductive success. Their conclusion was that by eating a diet that leads to longevity one will need to do so at the expense of growth and reproduction.

Eric Lefkofsky Brings Technology To Healthcare

Doctors were always aware that there was little information available on cancer. But somehow there was little that they could do about it. Even though there are cancer patients around the country, there was no comprehensive data available on it at one place. This was harming the doctors as they had no data for providing information in case they were looking at a treatment plan. In the end, it impacted the cancer patients the most.

Eric realized this once his wife was diagnosed with cancer. When he looked for more information regarding cancer diagnosis, he came across the absence of data and analysis with regard to cancer and its treatment.

This was when Lefkofsky came up with the idea of having an operating platform that can collate data on cancer patients across the country. This was how Tempus was founded. Next, he added on an analyzing service that could look at the treatment plans, the drugs being administered and the genetic makeup of the cancer patient. This allowed doctors to get access to a variety of treatment options.

Now if a doctor wanted to change a drug for a particular cancer patient, he could easily check out its impact on another patient with similar medical conditions and genetic makeup. This way the doctor will be prepared for the impact as well as after effects of that drug on the patient without even administering it. Lefkofsky at Facebook .

Eric Lefkofsky is highly excited with this venture. He is happy that he has been able to bring technology to the treatment of cancer. Ultimately it is all about combining technology with health care in order to benefit the patients.

Tempus is held and operated privately. This means that Eric Lefkofsky will not be answerable to any shareholders as it is not a public company.

For him, Tempus is personal business. He has been able to align each part of his family, business as well as philanthropy to Tempus. He finds a perfect symmetry here.

The fact is that 600,000 people are dying each year from cancer. The past 25 years have not seen much change in these figures. Eric Lefkofsky feels that having additional information can change treatment decisions. for more .